Headworks Bio Grants Use of Biofilm Carriers to IDI
Headworks Bio Inc. has signed an agreement with Infilco Degremont (IDI) following its recent acquisition of Hydroxyl Systems, Inc. Originally a licensee of Hydroxyl, IDI will continue to pursue the Integrated Fixed-film Activated Sludge/Moving Bed Biofilm Reactor (IFAS/MBBR) market under the terms of a new agreement with Headworks Bio, with full access to the ActiveCell® Biofilm Carriers.
Headworks Bio’s Chief Executive Officer Michele LaNoue explained why the company made the agreement: “MBBR/IFAS systems require deep expertise based on years of experience. It is not simply a matter, as some would think, of throwing a bunch of plastic bits into the system and hoping for the best. Although IDI and Headworks continue to compete in the market, we both agree that a certain degree of collaboration on projects that were jointly developed with the former Hydroxyl company benefits all involved. In this way, both of our companies continue to improve our already well established expertise in this emerging technology. This is good for the technology’s acceptance in the market as well as for the ultimate customers.”
MBBR technology is a biological wastewater treatment process that is more efficient than conventional or membrane wastewater treatment systems. It is not only more cost efficient, but requires less energy and space, both paramount considerations in the extremely limited confines of ships. Hydroxyl was one of the first of two companies to develop MBBR technology for use in municipalities and industrial applications and became the world leader in marine wastewater treatment.
Headworks Bio Inc. and its sister company, Headworks Inc., are Houston, Texas-based engineering and manufacturing companies supplying biological systems and liquid/solid separation equipment to the industrial, marine, and municipal wastewater treatment industry around the world.